{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:47:17Z","timestamp":1793929637534,"version":"4.8.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Biomed. Eng"],"DOI":"10.1038\/s41551-025-01517-2","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T09:02:35Z","timestamp":1758531755000},"page":"920-938","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Intranasal vaccine combining adenovirus and trimeric subunit protein provides superior immunity against SARS-CoV-2 Omicron variant"],"prefix":"10.1038","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1668-2301","authenticated-orcid":false,"given":"Weiqi","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huashan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3742-630X","authenticated-orcid":false,"given":"Jiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-6616","authenticated-orcid":false,"given":"Xiangyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhe","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aqu","family":"Alu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayuan","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiying","family":"Que","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyi","family":"Ao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunjun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MinYang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8177-7641","authenticated-orcid":false,"given":"Hongbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5022-3494","authenticated-orcid":false,"given":"Haohao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9326-0554","authenticated-orcid":false,"given":"Jian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1083-9729","authenticated-orcid":false,"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6768-2382","authenticated-orcid":false,"given":"Xikun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7788-1895","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guobo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2853-2696","authenticated-orcid":false,"given":"Xiangrong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuquan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-9735","authenticated-orcid":false,"given":"Shuaiyao","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-3827","authenticated-orcid":false,"given":"Qiangming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7568-592X","authenticated-orcid":false,"given":"Guangwen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9769-5141","authenticated-orcid":false,"given":"Youchun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7880-2113","authenticated-orcid":false,"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0985-0311","authenticated-orcid":false,"given":"Weimin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6513-6422","authenticated-orcid":false,"given":"Xiawei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"1517_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S1473-3099(23)00051-8","volume":"23","author":"K Uriu","year":"2023","unstructured":"Uriu, K. et al. Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant. Lancet Infect. Dis. 23, 280\u2013281 (2023).","journal-title":"Lancet Infect. Dis."},{"key":"1517_CR2","doi-asserted-by":"publisher","first-page":"2270069","DOI":"10.1080\/22221751.2023.2270069","volume":"12","author":"JN Faraone","year":"2023","unstructured":"Faraone, J. N. et al. Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3. Emerg. Microbes Infect. 12, 2270069 (2023).","journal-title":"Emerg. Microbes Infect."},{"key":"1517_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29359","volume":"96","author":"A Ciccozzi","year":"2024","unstructured":"Ciccozzi, A. et al. The mutation point of view of the SARS-CoV-2 HV.1 lineage. J. Med. Virol. 96, e29359 (2024).","journal-title":"J. Med. Virol."},{"key":"1517_CR4","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/S1473-3099(23)00744-2","volume":"24","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. Lancet Infect. Dis. 24, e70\u2013e72 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1517_CR5","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/s41564-023-01505-9","volume":"8","author":"CQ Huang","year":"2023","unstructured":"Huang, C. Q., Vishwanath, S., Carnell, G. W., Chan, A. C. Y. & Heeney, J. L. Immune imprinting and next-generation coronavirus vaccines. Nat. Microbiol. 8, 1971\u20131985 (2023).","journal-title":"Nat. Microbiol."},{"key":"1517_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1517_CR7","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1517_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99\u2013111 (2021).","journal-title":"Lancet"},{"key":"1517_CR9","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","volume":"397","author":"DY Logunov","year":"2021","unstructured":"Logunov, D. Y. et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia. Lancet 397, 671\u2013681 (2021).","journal-title":"Lancet"},{"key":"1517_CR10","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1056\/NEJMoa2034201","volume":"384","author":"J Sadoff","year":"2021","unstructured":"Sadoff, J. et al. Interim results of a phase 1\u20132a trial of Ad26.COV2.S Covid-19 vaccine. N. Engl. J. Med. 384, 1824\u20131835 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1517_CR11","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/0194599820982633","volume":"164","author":"BS Bleier","year":"2021","unstructured":"Bleier, B. S., Ramanathan, M. Jr. & Lane, A. P. COVID-19 vaccines may not prevent nasal SARS-CoV-2 infection and asymptomatic transmission. Otolaryngol. Head Neck Surg. 164, 305\u2013307 (2021).","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"1517_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019Kovski","year":"2021","unstructured":"V\u2019Kovski, P., Kratzel, A., Steiner, S., Stalder, H. & Thiel, V. Coronavirus biology and replication: implications for SARS-CoV-2. Nat. Rev. Microbiol. 19, 155\u2013170 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"1517_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abf1555","volume":"13","author":"Z Wang","year":"2021","unstructured":"Wang, Z. et al. Enhanced SARS-CoV-2 neutralization by dimeric IgA. Sci. Transl. Med. 13, eabf1555 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1517_CR14","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.cell.2022.02.005","volume":"185","author":"S Afkhami","year":"2022","unstructured":"Afkhami, S. et al. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell 185, 896\u2013915.e19 (2022).","journal-title":"Cell"},{"key":"1517_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27063-4","volume":"12","author":"D Lapuente","year":"2021","unstructured":"Lapuente, D. et al. Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization. Nat. Commun. 12, 6871 (2021).","journal-title":"Nat. Commun."},{"key":"1517_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","volume":"183","author":"AO Hassan","year":"2020","unstructured":"Hassan, A. O. et al. A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2. Cell 183, 169\u2013184.e13 (2020).","journal-title":"Cell"},{"key":"1517_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abh0755","volume":"13","author":"N van Doremalen","year":"2021","unstructured":"van Doremalen, N. et al. Intranasal ChAdOx1 nCoV-19\/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models. Sci. Transl. Med. 13, eabh0755 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1517_CR18","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","volume":"67","author":"J Chen","year":"2022","unstructured":"Chen, J. et al. A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2. Sci. Bull. 67, 1372\u20131387 (2022).","journal-title":"Sci. Bull."},{"key":"1517_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abi5246","volume":"7","author":"D An","year":"2021","unstructured":"An, D. et al. Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine. Sci. Adv. 7, eabi5246 (2021).","journal-title":"Sci. Adv."},{"key":"1517_CR20","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41541-022-00509-6","volume":"7","author":"MF Tioni","year":"2022","unstructured":"Tioni, M. F. et al. Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2. npj Vaccines 7, 85 (2022).","journal-title":"npj Vaccines"},{"key":"1517_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26499-y","volume":"12","author":"W Sun","year":"2021","unstructured":"Sun, W. et al. A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses. Nat. Commun. 12, 6197 (2021).","journal-title":"Nat. Commun."},{"key":"1517_CR22","doi-asserted-by":"publisher","first-page":"16757","DOI":"10.1021\/acsnano.2c06350","volume":"16","author":"JH Lam","year":"2022","unstructured":"Lam, J. H. et al. Artificial cell membrane polymersome-based intranasal beta spike formulation as a second generation Covid-19 vaccine. ACS Nano 16, 16757\u201316775 (2022).","journal-title":"ACS Nano"},{"key":"1517_CR23","doi-asserted-by":"publisher","first-page":"781280","DOI":"10.3389\/fimmu.2021.781280","volume":"12","author":"PA van der Ley","year":"2021","unstructured":"van der Ley, P. A., Zariri, A., van Riet, E., Oosterhoff, D. & Kruiswijk, C. P. An intranasal OMV-based vaccine induces high mucosal and systemic protecting immunity against a SARS-CoV-2 infection. Front. Immunol. 12, 781280 (2021).","journal-title":"Front. Immunol."},{"key":"1517_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38066-8","volume":"14","author":"H Lei","year":"2023","unstructured":"Lei, H. et al. Cationic crosslinked carbon dots-adjuvanted intranasal vaccine induces protective immunity against Omicron-included SARS-CoV-2 variants. Nat. Commun. 14, 2678 (2023).","journal-title":"Nat. Commun."},{"key":"1517_CR25","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3390\/vaccines9070768","volume":"9","author":"T Jearanaiwitayakul","year":"2021","unstructured":"Jearanaiwitayakul, T. et al. Intranasal administration of RBD nanoparticles confers induction of mucosal and systemic immunity against SARS-CoV-2. Vaccines 9, 768 (2021).","journal-title":"Vaccines"},{"key":"1517_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34297-3","volume":"13","author":"AS Ashhurst","year":"2022","unstructured":"Ashhurst, A. S. et al. Mucosal TLR2-activating protein-based vaccination induces potent pulmonary immunity and protection against SARS-CoV-2 in mice. Nat. Commun. 13, 6972 (2022).","journal-title":"Nat. Commun."},{"key":"1517_CR27","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41541-023-00665-3","volume":"8","author":"BK Diallo","year":"2023","unstructured":"Diallo, B. K. et al. Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection. npj Vaccines 8, 68 (2023).","journal-title":"npj Vaccines"},{"key":"1517_CR28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/vaccines9020132","volume":"9","author":"SS Chandrasekar","year":"2021","unstructured":"Chandrasekar, S. S. et al. Localized and systemic immune responses against SARS-CoV-2 following mucosal immunization. Vaccines 9, 132 (2021).","journal-title":"Vaccines"},{"key":"1517_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adh1655","volume":"9","author":"G Baldeon Vaca","year":"2023","unstructured":"Baldeon Vaca, G. et al. Intranasal mRNA-LNP vaccination protects hamsters from SARS-CoV-2 infection. Sci. Adv. 9, eadh1655 (2023).","journal-title":"Sci. Adv."},{"key":"1517_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103841","volume":"76","author":"A Alu","year":"2022","unstructured":"Alu, A. et al. Intranasal COVID-19 vaccines: from bench to bed. EBioMedicine 76, 103841 (2022).","journal-title":"EBioMedicine"},{"key":"1517_CR31","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41541-023-00654-6","volume":"8","author":"JM Knisely","year":"2023","unstructured":"Knisely, J. M. et al. Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities\u2013workshop report. npj Vaccines 8, 53 (2023).","journal-title":"npj Vaccines"},{"key":"1517_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jama.2022.22759","volume":"329","author":"PW Marks","year":"2023","unstructured":"Marks, P. W., Gruppuso, P. A. & Adashi, E. Y. Urgent need for next-generation COVID-19 vaccines. JAMA 329, 19\u201320 (2023).","journal-title":"JAMA"},{"key":"1517_CR33","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.molmed.2022.10.009","volume":"29","author":"R Nakahashi-Ouchida","year":"2023","unstructured":"Nakahashi-Ouchida, R., Fujihashi, K., Kurashima, Y., Yuki, Y. & Kiyono, H. Nasal vaccines: solutions for respiratory infectious diseases. Trends Mol. Med. 29, 124\u2013140 (2023).","journal-title":"Trends Mol. Med."},{"key":"1517_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104298","volume":"85","author":"M Madhavan","year":"2022","unstructured":"Madhavan, M. et al. Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: an open-label partially-randomised ascending dose phase I trial. EBioMedicine 85, 104298 (2022).","journal-title":"EBioMedicine"},{"key":"1517_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41541-023-00717-8","volume":"8","author":"C Singh","year":"2023","unstructured":"Singh, C. et al. Phase III pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin\u00ae). npj Vaccines 8, 125 (2023).","journal-title":"npj Vaccines"},{"key":"1517_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41541-023-00662-6","volume":"8","author":"S Ponce-de-Le\u00f3n","year":"2023","unstructured":"Ponce-de-Le\u00f3n, S. et al. Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico. npj Vaccines 8, 67 (2023).","journal-title":"npj Vaccines"},{"key":"1517_CR37","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1016\/j.drudis.2021.07.021","volume":"26","author":"VP Chavda","year":"2021","unstructured":"Chavda, V. P., Vora, L. K., Pandya, A. K. & Patravale, V. B. Intranasal vaccines for SARS-CoV-2: from challenges to potential in COVID-19 management. Drug Discov. Today 26, 2619\u20132636 (2021).","journal-title":"Drug Discov. Today"},{"key":"1517_CR38","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41392-022-01002-1","volume":"7","author":"H Lei","year":"2022","unstructured":"Lei, H. et al. Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants. Signal Transduct. Target. Ther. 7, 159 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1517_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-13819-5","volume":"12","author":"FC Stark","year":"2022","unstructured":"Stark, F. C. et al. Intranasal immunization with a proteosome-adjuvanted SARS-CoV-2 spike protein-based vaccine is immunogenic and efficacious in mice and hamsters. Sci. Rep. 12, 9772 (2022).","journal-title":"Sci. Rep."},{"key":"1517_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17972-1","volume":"11","author":"S Wu","year":"2020","unstructured":"Wu, S. et al. A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge. Nat. Commun. 11, 4081 (2020).","journal-title":"Nat. Commun."},{"key":"1517_CR41","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1089\/hum.2014.001","volume":"25","author":"R Hendrickx","year":"2014","unstructured":"Hendrickx, R. et al. Innate immunity to adenovirus. Hum. Gene Ther. 25, 265\u2013284 (2014).","journal-title":"Hum. Gene Ther."},{"key":"1517_CR42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1556\/EuJMI.1.2011.4.3","volume":"1","author":"G Fejer","year":"2011","unstructured":"Fejer, G., Freudenberg, M., Greber, U. F. & Gyory, I. Adenovirus-triggered innate signalling pathways. Eur. J. Microbiol. Immunol. 1, 279\u2013288 (2011).","journal-title":"Eur. J. Microbiol. Immunol."},{"key":"1517_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1146\/annurev-virology-092818-015550","volume":"6","author":"UF Greber","year":"2019","unstructured":"Greber, U. F. & Flatt, J. W. Adenovirus entry: from infection to immunity. Annu. Rev. Virol. 6, 177\u2013197 (2019).","journal-title":"Annu. Rev. Virol."},{"key":"1517_CR44","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1146\/annurev-immunol-032712-095910","volume":"31","author":"JS Blum","year":"2013","unstructured":"Blum, J. S., Wearsch, P. A. & Cresswell, P. Pathways of antigen processing. Annu. Rev. Immunol. 31, 443\u2013473 (2013).","journal-title":"Annu. Rev. Immunol."},{"key":"1517_CR45","doi-asserted-by":"publisher","first-page":"102210","DOI":"10.1016\/j.coi.2022.102210","volume":"77","author":"N McCann","year":"2022","unstructured":"McCann, N., O\u2019Connor, D., Lambe, T. & Pollard, A. J. Viral vector vaccines. Curr. Opin. Immunol. 77, 102210 (2022).","journal-title":"Curr. Opin. Immunol."},{"key":"1517_CR46","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1126\/science.1137971","volume":"316","author":"S Burgdorf","year":"2007","unstructured":"Burgdorf, S., Kautz, A., B\u00f6hnert, V., Knolle, P. A. & Kurts, C. Distinct pathways of antigen uptake and intracellular routing in CD4 and CD8 T cell activation. Science 316, 612\u2013616 (2007).","journal-title":"Science"},{"key":"1517_CR47","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41541-023-00637-7","volume":"8","author":"E Saeland","year":"2023","unstructured":"Saeland, E. et al. Combination Ad26.RSV.preF\/preF protein vaccine induces superior protective immunity compared with individual vaccine components in preclinical models. npj Vaccines 8, 45 (2023).","journal-title":"npj Vaccines"},{"key":"1517_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.chom.2024.01.014","volume":"32","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1. Cell Host Microbe 32, 315\u2013321.e3 (2024).","journal-title":"Cell Host Microbe"},{"key":"1517_CR49","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/S1473-3099(23)00690-4","volume":"24","author":"MV Stankov","year":"2024","unstructured":"Stankov, M. V. et al. Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination. Lancet Infect. Dis. 24, e1\u2013e3 (2024).","journal-title":"Lancet Infect. Dis."},{"key":"1517_CR50","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1056\/NEJMc2402779","volume":"390","author":"DY Lin","year":"2024","unstructured":"Lin, D. Y. et al. Durability of XBB.1.5 vaccines against Omicron subvariants. N. Engl. J. Med. 390, 2124\u20132127 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1517_CR51","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.263","volume":"4","author":"C He","year":"2023","unstructured":"He, C. et al. A recombinant spike-XBB.1.5 protein vaccine induces broad-spectrum immune responses against XBB.1.5-included Omicron variants of SARS-CoV-2. MedComm 4, e263 (2023).","journal-title":"MedComm"},{"key":"1517_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33209-9","volume":"13","author":"C He","year":"2022","unstructured":"He, C. et al. A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant. Nat. Commun. 13, 5459 (2022).","journal-title":"Nat. Commun."},{"key":"1517_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-55087-z","volume":"15","author":"J Yang","year":"2024","unstructured":"Yang, J. et al. Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials. Nat. Commun. 15, 10778 (2024).","journal-title":"Nat. Commun."},{"key":"1517_CR54","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/s41392-024-01906-0","volume":"9","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies. Signal Transduct. Target. Ther. 9, 190 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1517_CR55","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.hlife.2024.05.004","volume":"2","author":"S Chen","year":"2024","unstructured":"Chen, S. et al. Nasal mucosal secretory immunoglobulin A but not serum antibodies is resistant to Omicron evasion. hLife 2, 488\u2013491 (2024).","journal-title":"hLife"},{"key":"1517_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-021-00657-1","volume":"22","author":"BJ Laidlaw","year":"2022","unstructured":"Laidlaw, B. J. & Ellebedy, A. H. The germinal centre B cell response to SARS-CoV-2. Nat. Rev. Immunol. 22, 7\u201318 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"1517_CR57","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2021.12.026","volume":"185","author":"PA Mudd","year":"2022","unstructured":"Mudd, P. A. et al. SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans. Cell 185, 603\u2013613.e15 (2022).","journal-title":"Cell"},{"key":"1517_CR58","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41392-023-01495-4","volume":"8","author":"J Yang","year":"2023","unstructured":"Yang, J. et al. Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection. Signal Transduct. Target. Ther. 8, 252 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1517_CR59","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S2213-2600(22)00131-X","volume":"10","author":"F Zhu","year":"2022","unstructured":"Zhu, F. et al. Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Respir. Med. 10, 749\u2013760 (2022).","journal-title":"Lancet Respir. Med."},{"key":"1517_CR60","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","volume":"397","author":"EJ Haas","year":"2021","unstructured":"Haas, E. J. et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 397, 1819\u20131829 (2021).","journal-title":"Lancet"},{"key":"1517_CR61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104435","volume":"88","author":"L Azzi","year":"2023","unstructured":"Azzi, L. et al. Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine. EBioMedicine 88, 104435 (2023).","journal-title":"EBioMedicine"},{"key":"1517_CR62","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1126\/science.adc9127","volume":"378","author":"YJ Park","year":"2022","unstructured":"Park, Y. J. et al. Imprinted antibody responses against SARS-CoV-2 Omicron sublineages. Science 378, 619\u2013627 (2022).","journal-title":"Science"},{"key":"1517_CR63","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.180784","volume":"9","author":"B Sun","year":"2024","unstructured":"Sun, B. et al. An intranasally administered adenovirus-vectored SARS-CoV-2 vaccine induces robust mucosal secretory IgA. JCI Insight 9, e180784 (2024).","journal-title":"JCI Insight"},{"key":"1517_CR64","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260\u20131263 (2020).","journal-title":"Science"},{"key":"1517_CR65","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jconrel.2021.05.024","volume":"335","author":"H Huang","year":"2021","unstructured":"Huang, H. et al. The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2. J. Control. Release 335, 449\u2013456 (2021).","journal-title":"J. Control. Release"},{"key":"1517_CR66","unstructured":"Hong, W., Pan, X. & Wei, X. Two-component intranasal vaccine against SARS-CoV-2 Omicron variant. NCBI GEO https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE279004 (2025)."},{"key":"1517_CR67","unstructured":"Pan, X. Vaccine-against-SARS-CoV-2. Source code. GitHub https:\/\/github.com\/pangxueyu233\/Vaccine-against-SARS-CoV-2 (2025)."}],"container-title":["Nature Biomedical Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01517-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01517-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01517-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T22:11:50Z","timestamp":1779315110000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41551-025-01517-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":67,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["1517"],"URL":"https:\/\/doi.org\/10.1038\/s41551-025-01517-2","relation":{},"ISSN":["2157-846X"],"issn-type":[{"value":"2157-846X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"11 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was supported by WestVac Biopharma Co. Ltd. P.C., Jingyun Yang, Z.W., Jiong Li, W.W., G.S., Jinliang Yang, Y. Wei, G.L., L.Y. and X.W. are employees of WestVac Biopharma Co. Ltd. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}